Preliminary Evaluation of the Safety and Immunogenicity of an Antimalarial Vaccine Candidate Modified Peptide (IMPIPS) Mixture in a Murine Model

Table 2

Single dose: distribution of the groups of mice according to treatment.

	Treatment	Size
Group 1	Physiological saline solution (PSS) (control)	3M+3F
Group 2	IMPIPS mixture (30 μg in total)+PSS (1 : 1)	3M+3F
Group 3	IMPIPS mixture (30 μg in total)+Freund’s adjuvant (1 : 1)	3M+3F

The immunisation was made with complete Freund’s adjuvant.